Log in

OTCMKTS:NVZMFNovozymes A/S Stock Price, Forecast & News

$58.00
+1.11 (+1.95 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$58.00
Now: $58.00
$58.00
50-Day Range
$49.72
MA: $54.81
$58.00
52-Week Range
$35.25
Now: $58.00
$58.60
Volume930 shs
Average Volume2,174 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Novozymes A/S produces and sells industrial enzymes and microorganisms worldwide. The company offers agriculture solutions, including crop protection, and animal health and nutrition solutions; fermentation, lignecellulosic hydrolysis, liquefaction, process enhancement, and saccharifaction solutions for bioenergy; baking, beverages, dairy, and protein ingredients for the food and beverage industry; and laundry, dishwashing, hand washing, and cleaning solutions for the household care industry. It also provides wastewater solutions, such as additives, biogas production, industrial bio cleaning, compound removal, odor control, and system start-up solutions; and textile solutions comprising bioscouring, bleach clean-up, desizing, denim finishing and abrasion, and biopolishing solutions. In addition, the company offers forest products that include bleach boosting, deinking, fiber modification, effluent control, pitch and stickies control, and starch modification products; and leather solutions, which comprise biopreparation, degreasing, and re-bating. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis; and rtrypsin for cell culture. Novozymes A/S has a strategic collaboration with Boehringer Ingelheim Animal Health for the research and development, production, marketing, and sale of a portfolio of probiotic products. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.40 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NVZMF
CUSIPN/A
Phone+45-44-460000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees6,131
Next Earnings DateN/A
OptionableNot Optionable

Receive NVZMF News and Ratings via Email

Sign-up to receive the latest news and ratings for NVZMF and its competitors with MarketBeat's FREE daily newsletter.

Novozymes A/S (OTCMKTS:NVZMF) Frequently Asked Questions

How has Novozymes A/S's stock been impacted by COVID-19 (Coronavirus)?

Novozymes A/S's stock was trading at $45.90 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NVZMF shares have increased by 26.4% and is now trading at $58.00. View which stocks have been most impacted by Coronavirus.

How were Novozymes A/S's earnings last quarter?

Novozymes A/S (OTCMKTS:NVZMF) issued its earnings results on Wednesday, April, 20th. The biotechnology company reported $0.37 earnings per share for the quarter, missing the Zacks' consensus estimate of $2.43 by $2.06. View Novozymes A/S's earnings history.

Has Novozymes A/S been receiving favorable news coverage?

Media headlines about NVZMF stock have trended negative on Saturday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Novozymes A/S earned a daily sentiment score of -2.8 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 7.0 out of 10, indicating that recent media coverage is likely to have an effect on the company's share price in the immediate future. View the latest news about Novozymes A/S.

Who are some of Novozymes A/S's key competitors?

Who are Novozymes A/S's key executives?

Novozymes A/S's management team includes the following people:
  • Mr. Peder Holk Nielsen, Pres & CEO (Age 63)
  • Dr. Prisca Havranek-Kosicek, CFO & Exec. VP of Corp. Functions (Age 44)
  • Mr. Thomas Videbaek, Exectuive VP & COO of Research, Innovation & Supply (Age 59)
  • Mr. Andrew Fordyce, Exec. VP of Food & Beverages (Age 56)
  • Mr. Anders Lund, Exec. VP of Household Care & Technical Industries (Age 46)

What is Novozymes A/S's stock symbol?

Novozymes A/S trades on the OTCMKTS under the ticker symbol "NVZMF."

How do I buy shares of Novozymes A/S?

Shares of NVZMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Novozymes A/S's stock price today?

One share of NVZMF stock can currently be purchased for approximately $58.00.

What is Novozymes A/S's official website?

The official website for Novozymes A/S is www.novozymes.com.

How can I contact Novozymes A/S?

Novozymes A/S's mailing address is Krogshoejvej 36, BAGSVAERD, 2880, Denmark. The biotechnology company can be reached via phone at +45-44-460000.

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.